# Treatment of Hepatitis c by Using Direct-acting Antiviral

> **NCT05372874** · — · UNKNOWN · sponsor: **Tanta University** · enrollment: 50 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Direct Acting Antivirals

## Key facts

- **NCT ID:** NCT05372874
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-06
- **Primary completion:** 2022-07-12
- **Final completion:** 2022-07-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05372874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05372874, "Treatment of Hepatitis c by Using Direct-acting Antiviral". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05372874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*